Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Nuvalent, Inc. (NUVL)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 73,500,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Nuvalent is a biopharmaceutical company. Co.'s product candidate, NVL-520, is a ROS proto-oncogene 1 (ROS1)-selective inhibitor designed with the aim to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of available ROS1 tyrosine kinase inhibitors. Co.'s another product candidate, NVL-655, is a brain-penetrant anaplastic lymphoma kinase (ALK)-selective inhibitor, designed with the aim to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that may limit the use of first-, second-, and third-generation ALK inhibitors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 172,883 324,528 3,844,324 5,628,332
Total Sell Value $14,273,564 $26,136,144 $353,096,666 $483,765,603
Total People Sold 4 4 9 11
Total Sell Transactions 14 28 53 107
End Date 2025-07-20 2025-04-18 2024-10-18 2023-10-19

   
Records found: 338
  Page 1 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Miller Deborah Ann Chief Legal Officer   •       –      –    2025-10-16 4 AS $90.54 $1,134,442 D/D (12,376) 49,086     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2025-10-16 4 OE $6.89 $85,271 D/D 12,376 61,462     -
   Porter James Richard President and CEO   •       •      –    2025-10-16 4 AS $90.01 $2,447,021 D/D (27,000) 249,062     -
   Porter James Richard President and CEO   •       •      –    2025-10-16 4 OE $18.93 $511,110 D/D 27,000 276,062     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2025-10-15 4 AS $89.98 $1,405,848 D/D (15,624) 49,086     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2025-10-15 4 OE $6.89 $107,649 D/D 15,624 64,710     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-10-15 4 AS $85.57 $144,014 D/D (1,683) 61,734     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-10-15 4 OE $18.93 $31,859 D/D 1,683 63,417     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-10-15 4 AS $90.04 $1,279,018 D/D (14,205) 65,963     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-10-15 4 OE $18.93 $498,260 D/D 14,205 80,168     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-10-14 4 AS $84.98 $208,699 D/D (2,433) 65,963     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-10-14 4 OE $18.93 $62,460 D/D 2,433 68,396     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-10-14 4 AS $85.75 $1,724,016 D/D (20,000) 61,734     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-10-14 4 OE $18.93 $378,600 D/D 20,000 81,734     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-10-13 4 AS $89.81 $685,879 D/D (7,637) 65,963     -
   Pelish Henry E. Chief Scientific Officer   •       –      –    2025-10-13 4 OE $18.93 $277,903 D/D 7,637 73,600     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-10-13 4 AS $87.90 $1,770,288 D/D (20,000) 61,734     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-10-13 4 OE $6.89 $295,825 D/D 20,000 81,734     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-10-01 4 AS $85.43 $1,709,512 D/D (20,000) 61,734     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-10-01 4 OE $6.89 $176,485 D/D 20,000 81,734     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-09-30 4 AS $85.06 $1,701,200 D/D (20,000) 61,734     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-09-30 4 OE $6.89 $137,800 D/D 20,000 81,734     -
   Noci Darlene Chief Development Officer   •       –      –    2025-09-29 4 AS $81.39 $332,288 D/D (4,000) 48,034     -
   Noci Darlene Chief Development Officer   •       –      –    2025-09-29 4 OE $27.85 $111,400 D/D 4,000 52,034     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2025-09-29 4 AS $85.01 $645,056 D/D (7,588) 61,734     -
  338 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us